← Back to Search

Mindful Motivation Group for Binge Eating

N/A
Waitlist Available
Led By Rachel Radin, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Study 1
* Aged 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to post-intervention, an anticipated average of 8 weeks
Awards & highlights

Summary

The aim of this study is to test how acceptable and feasible a new eating intervention is in people with overweight and binge eating. This intervention combines mindful eating with motivational interviewing to target binge eating. The main questions this clinical trial aims to answer are: How well do participants accept the new intervention (acceptability)? Is the intervention practical and easy to implement (feasibility)? In this trial researchers will compare the new eating intervention (motivational interviewing for mindful eating + digital meditation) to an active control (digital meditation) to see if the intervention can help reduce binge eating. Participants will: 1. Take online questionnaires at four different time points 2. Provide body composition and samples to measure glucose levels 3. Meditate for at least 10 minutes a day 4. If assigned to the Mindful Motivation group, 8 weeks of brief counseling

Who is the study for?
This trial is for individuals who are overweight and struggle with binge eating. Participants will be asked to complete online questionnaires, provide body composition data, and meditate daily. They must not have conditions that exclude them from the study.
What is being tested?
The trial tests a new intervention combining mindful eating techniques with motivational interviewing against an active control of digital meditation alone. The goal is to see if this approach can reduce binge eating episodes.
What are the potential side effects?
Since the interventions involve behavioral strategies like meditation and counseling, side effects may include increased self-awareness or emotional discomfort but typically do not involve physical side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to post-intervention, an anticipated average of 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to post-intervention, an anticipated average of 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Client Satisfaction score, as determined by the total score on the Client Satisfaction Questionnaire (CSQ-8)
Change in Credibility/Expectancy and Satisfaction Questionnaire (CEQ) score, as determined by total score on the CEQ
Percentage of participants attending a booster call # 1
+4 more
Secondary study objectives
Change in Questionnaire on Eating and Weight Patterns (QEWP) frequency of binge eating episodes per month
Change in Reward Based Eating Drive Scale (RED-13) score, as determined by total score on the RED-13.
Change in Weight Efficacy Lifestyle Scale (WEL-SF) score, as determined by total score on the WEL-SF
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindful Motivation GroupExperimental Treatment2 Interventions
Participants will be assigned to a eating intervention that combines general mindfulness (via headspace) with motivational interviewing for mindful eating They will be asked to attend an online counseling session along with three 10-minute booster phone calls. They will be asked to engage with a digital-based mindful eating program once per week over the course of 8 weeks. In addition, participants will have access to optional educational materials on mindful eating and an optional online private support forum after the intervention period is finished.
Group II: Active Control ConditionActive Control1 Intervention
Participants in the meditation intervention group will be assigned to a digitally-based meditation intervention (via Headspace) and asked to use this for at least 10 minutes a day over the course of 8 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meditation
2021
Completed Phase 3
~2600

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,537 Previous Clinical Trials
15,262,362 Total Patients Enrolled
DexCom, Inc.Industry Sponsor
140 Previous Clinical Trials
30,017 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
840 Previous Clinical Trials
672,212 Total Patients Enrolled
~67 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top